Intelligence

#CDMO #Collaboration #CRO #Drug development #Drug discovery #Guide

Streamline your drug development pathway

In pharmaceutical development, collaborating with multiple Contract Development and Manufacturing Organisations (CDMOs) and Contract Research Organisations (CROs) poses potential hurdles – from poor communication to delays, errors, and inconsistent feedback during the progression from preclinical to formulation optimisation and clinical trials. Download this SGS guide to discover: How to collaborate… Read More

#Intelligence #Resources

DDW Neuroscience Guide
#Drug development #Drug discovery #Guide #Neurology #Neuroscience #Precision psychiatry

Unlocking neuroscience drug discovery

DDW has published the latest addition to its Guide Series, ‘Unlocking neuroscience drug discovery’. It covers the way the neuroscience sector is overcoming drug discovery challenges, advances in neuroscience and the era of precision neuroscience. Download to find out: Neuroscience drug discovery advances and challenges and how breakthroughs in this… Read More

#DDW eBooks #DDW Guides

#Biologics #Biologics / Biotechnology #Drug discovery #Infographic

Stability assessment of biologics during early development workflows

During early development of biologics, there are a large number of attributes researchers evaluate, but some of the most common centre around stability – asking if a biologic is well-folded, active and pure in its buffer, and whether it remains that way over time. Biophysical characterisations are valuable for providing… Read More

#Intelligence #Resources

#Drug development #Drug discovery #Drug safety #Drug screening #Mitochondria #Toxicology

Measurement of mitochondrial toxicity using primary hepatocytes

Mitochondrial dysfunction is known to play a central role in drug-induced hepatotoxicity, and thus early detection of mitochondrial toxicity is a critical component of initial drug development efforts. While immortalised cell lines are widely used for in vitro assessment of hepatotoxicity, cryopreserved primary human hepatocytes are a preferred model for drug… Read More

#Resources

Seed fund
#BioInnovation Institute #Financing #Mental health #Plant-based #Start-ups

$3M funding for plant-inspired halogenated small molecule drugs

Biomia, the first company spun out from BioInnovation Institute’s Bio Studio programme, has secured $3 million in pre-seed financing from an international syndicate of investors. Biomia says it plans to use the investment to accelerate its development of plant-inspired natural and new-to-nature halogenated small molecule drug… Read More

#Business & Investment #News #Start-up Zone

#Drug discovery #In Focus Report #Synthetic biology #Synthetic DNA

Synthetic Biology: Is it the next big thing?

Download this exclusive DDW eReport to learn more about: The global market for synthetic biology: its potential and where innovative drug development is taking place Analysis of regional markets and the key players within the synthetic biology sector How advances in the synthetic biology field are impacting drug discovery – from… Read More

#DDW eBooks #DDW In Focus eReports #Intelligence

#Cancer research #Drug development #Drug discovery #Oncology #Screening

Learn about the rapid bioenergetic functional screening of anticancer drug candidates

The regulation of cellular bioenergetics is recognised as a key driver of cancer cell proliferation. Identifying key pathways that modulate bioenergetic metabolism is a promising strategy for developing novel therapeutics for cancer treatment. In this App Note you will learn: How the Agilent Seahorse XF Real Time ATP rate assay… Read More

#Resources

#Assays #Drug development #Drug discovery #Kinetics

Optimising kinetic assays to avoid avidity effects

What you will learn: Researchers from ChromoTek discuss the differences between affinity and avidity as measured on the Octet® BLI platform Measuring affinity in avidity driven assay orientations Why assay orientation, valency, ligand surface density and non-specific binding matter Recognise and resolve issues arising from interactions that contain a bivalent… Read More

#Resources

#Drug development #Drug discovery #mRNA #Purification technology #Screening

Discover how to achieve mRNA binding on Oligo dT with DBC values over 6mg/mL

In this Application Note, multi-parallel screening of binding conditions on CIM® Oligo dT 96-well plates was performed to optimise the dynamic binding capacity (DBC) in the shortest time possible. What you will learn: How to effectively use Monolithic 96-well plates when developing methods. They are unique on the market in combining the… Read More

#Resources

AI brain
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug discovery #Pharmaceutical industry

Pharma must embrace an AI future says new report

Artificial intelligence (AI) technology has the potential to revolutionise drug discovery and pharma companies need to make plans for a future in which AI is frequently utilised in research, says ResearchAndMarkets.com. However, the change AI will bring about in drug discovery will take some time, according… Read More

#News #Trends & Analysis

#Artificial intelligence (AI) #Assays #Cell culture #Cellular assays #Cellular imaging

Streamline migration assays with in-incubator monitoring

Cell migration assays can be time-consuming and challenging, from identifying and ensuring assays are imaged at the appropriate time, to properly measuring wound closure. Evident’s CM cell culture monitors provide label-free, quantitative results, consistent results throughout your lab, and are cost-effective. Researchers at ACEL simplified the cell migration process by… Read More

#Resources

#CDMO #Cell and gene therapy #Gene therapy #Manufacturing

Analytical methods for viral vector development and manufacturing in gene therapy

In the eleventh eBook of the Hamilton series ‘Analytical Methods for Viral Vector Development and Manufacturing in Gene Therapy’, we learn about: Gene therapy: history, viral vectors and the role of CDMOs Automation of analytical assays during viral vector development and manufacturing The solutions that Hamilton offers to customers working… Read More

#Resources